Molecular Assemblies, Inc.
Molecular Assemblies Inc.
- UEI
- ZBCUP43W5K34
- CAGE
- 6V8D9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- trilinkbiotech.com
- Founded
- 1996
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a fully enzymatic oligonucleotide synthesis cycle by engineered template independent polymerases and a… | National Human Genome Research Institute | $768,678 | |
| Modified nucleotidyl transferases for enzymatically mediated oligodeoxynucleotide synthesis | National Institutes of Health | $189,004 | |
| Non-templated enzymatic synthesis of polydeoxynucleotides | National Institutes of Health | $222,969 | |
| Sbir phase i: non-templated enzymatic synthesis of polydeoxynucleotides | National Science Foundation | $150,000 |
About Molecular Assemblies, Inc.
Molecular Assemblies, Inc. is a private life sciences company that develops enzymatic DNA synthesis technology to power the next generation of DNA-based products. The company utilizes patented Fully Enzymatic Synthesis to synthesize DNA through enzymatic rather than chemical means.
As a subcontractor, Molecular Assemblies has provided research and development services to support contracts held by prime contractors such as General Electric Company. Specific details on the nature of these subcontracted goods and services are unknown.
Through a prime project grant from the National Institutes of Health's National Human Genome Research Institute, Molecular Assemblies has developed a fully enzymatic oligonucleotide synthesis cycle using engineered template-independent polymerases and a novel phosphate dNTP blocking group. This research supports the Human Genome Research program's goals to accelerate genome research and its application to human health. Specifically, Molecular Assemblies engineered the template-independent polymerase Terminal Deoxynucleotidyl Transferase to improve incorporation of 3'-O-phosphate dNTPs, enabling fully enzymatic DNA synthesis. This $768,678 award, with a period of performance from August 2021 through January 2022, could enable optimizations to allow a proof-of-concept DNA synthesis using lead enzyme variants and 3'-O-phosphate nucleotides. Knowledge gained could guide further enzyme improvements toward longer, lower-error rate DNA synthesis to potentially replace chemical DNA manufacturing methods.
Quick answers
What is Molecular Assemblies, Inc.'s UEI?
Molecular Assemblies, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZBCUP43W5K34.
What is Molecular Assemblies, Inc.'s CAGE code?
Molecular Assemblies, Inc.'s CAGE code is 6V8D9.
What is Molecular Assemblies, Inc.'s primary NAICS code?
Molecular Assemblies, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Molecular Assemblies, Inc. registered in SAM.gov?
Molecular Assemblies, Inc.'s SAM.gov registration expired on March 14, 2025.
What is Molecular Assemblies, Inc.'s most recent federal award?
Molecular Assemblies, Inc.'s most recent federal grant award is Development of a fully enzymatic oligonucleotide synthesis cycle by engineered template independent polymerases and a… (R43HG011679), from National Human Genome Research Institute, on August 16, 2021.
On GovTribe
See Molecular Assemblies, Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors